Author： Fernandez H.H. Trieschmann M.E. Friedman J.H.
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.26, Iss.9, 2003-01, pp. : 643-659
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ropinirole in the treatment of Parkinson’s disease
Expert Opinion on Investigational Drugs, Vol. 8, Iss. 5, 1999-05 ,pp. :
Access to resources
Recommend
Pimavanserin for the treatment of Parkinson's disease psychosis
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 14, 2013-10 ,pp. :
Non-dopaminergic drug treatment of Parkinson’s disease
By Müller T.
Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 4, 2001-04 ,pp. :
Emerging Therapies in the Pharmacological Treatment of Parkinsons Disease
Drugs, Vol. 62, Iss. 5, 2002-01 ,pp. :